Ephedrine and pseudoephedrine products.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 3 Sponsors

Jan 8, 2026 · House

Coauthored by Representatives Miller D, Miller K

Jan 8, 2026 · House

First reading: referred to Committee on Veterans Affairs and Public Safety

Jan 8, 2026 · House

Authored by Representative Isa

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 13%, measured from IN's completed sessions
Momentum -4 31/100 from the pace of recorded action
Time since last action -22 275 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.